Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ceruloplasmin is a blue, copper-containing glycoprotein primarily synthesized in the liver. It serves as the major copper-carrying protein in human blood and plays essential roles in both copper and iron metabolism. It functions as a multicopper oxidase (ferroxidase), catalyzing oxidation reactions involving iron (Fe²⁺ to Fe³⁺) and other substrates. It also plays an antioxidant role and is involved in iron metabolism by facilitating iron mobilization. Ceruloplasmin expression is regulated during inflammatory states and its levels are diagnostic markers for Wilson and Menkes diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ceruloplasmin (CP).